1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 4-butyrolactone in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (4-butyrolactone) | Trials (4-butyrolactone) | Recent Studies (post-2010) (4-butyrolactone) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 4,456 | 78 | 1,823 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonjouklian, R; Phillips, ML | 1 |
| Clark, WF; Muir, AD; Parbtani, A; Westcott, ND | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 4-butyrolactone
| Article | Year |
|---|---|
Cyclic platelet-activating factor analogues derived from 2-deoxy-D-erythro-pentose.
Topics: 4-Butyrolactone; Furans; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Optical Rotation; Pentoses; Platelet Activating Factor; Platelet Aggregation; Spectrophotometry, Infrared; Structure-Activity Relationship | 1986 |
A novel treatment for lupus nephritis: lignan precursor derived from flax.
Topics: 4-Butyrolactone; Animals; Blood Coagulation Factors; Flax; Humans; Lignans; Lupus Nephritis; Mice; Phytotherapy; Platelet Activating Factor; Seeds | 2000 |